Company’s 36-month beta value is 0.94.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 2 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for NCNA is 43.24M, and currently, short sellers hold a 5.74% ratio of that floaft. The average trading volume of NCNA on April 01, 2024 was 1.61M shares.
NCNA) stock’s latest price update
The stock price of NuCana plc ADR (NASDAQ: NCNA) has dropped by -15.21 compared to previous close of 0.31. Despite this, the company has seen a fall of -10.25% in its stock price over the last five trading days. InvestorPlace reported 2024-03-13 that NuCana (NASDAQ: NCNA ) stock is rising on Wednesday as the clinical-stage biopharmaceutical company’s shares experience heavy trading this morning. That has more than 9.6 million shares of the company’s stock changing hands as of this writing.
NCNA’s Market Performance
NCNA’s stock has fallen by -10.25% in the past week, with a monthly drop of -20.80% and a quarterly drop of -13.33%. The volatility ratio for the week is 10.52% while the volatility levels for the last 30 days are 16.17% for NuCana plc ADR The simple moving average for the past 20 days is -22.52% for NCNA’s stock, with a -49.98% simple moving average for the past 200 days.
Analysts’ Opinion of NCNA
Truist, on the other hand, stated in their research note that they expect to see NCNA reach a price target of $22. The rating they have provided for NCNA stocks is “Buy” according to the report published on October 22nd, 2020.
NCNA Trading at -18.66% from the 50-Day Moving Average
After a stumble in the market that brought NCNA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -73.97% of loss for the given period.
Volatility was left at 16.17%, however, over the last 30 days, the volatility rate increased by 10.52%, as shares sank -18.75% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -9.72% lower at present.
During the last 5 trading sessions, NCNA fell by -10.25%, which changed the moving average for the period of 200-days by -66.15% in comparison to the 20-day moving average, which settled at $0.3326. In addition, NuCana plc ADR saw -12.10% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for NCNA
The total capital return value is set at -2.17. Equity return is now at value -105.09, with -65.02 for asset returns.
Based on NuCana plc ADR (NCNA), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -66.77. The debt to equity ratio resting at 0.03. The interest coverage ratio of the stock is -29.72.
Currently, EBITDA for the company is -47.58 million with net debt to EBITDA at 0.58. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.97.
Conclusion
In a nutshell, NuCana plc ADR (NCNA) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
